Atlas Trials

RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)

Clinical trial NCT05134012 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05134012
Sponsor
MedTrace Pharma A/S
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Coronary Artery Disease
Start date
2022-05-08
Primary completion
2026-10-01
Enrollment
215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.